Published in Thromb Haemost on June 01, 2007
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23
Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost (2011) 1.19
Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost (2011) 1.09
Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med (2009) 0.97
Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis (2016) 0.96
P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis. Thromb Res (2009) 0.94
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thromb Res (2011) 0.88
Mean platelet volume: is it a predictive parameter in the diagnosis of sudden sensorineural hearing loss? Indian J Otolaryngol Head Neck Surg (2013) 0.81
Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system. Blood Transfus (2012) 0.80
Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord (2013) 0.80
The red blood cell as a gender-associated biomarker in metabolic syndrome: a pilot study. Int J Cell Biol (2011) 0.80
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res (2015) 0.77
Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study. Thromb Res (2012) 0.75
A Novel Prioritization Method in Identifying Recurrent Venous Thromboembolism-Related Genes. PLoS One (2016) 0.75
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
The risk of recurrent venous thromboembolism in men and women. N Engl J Med (2004) 7.41
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med (2004) 3.63
Deep vein thrombosis. Lancet (2005) 3.43
Risk assessment for recurrent venous thrombosis. Lancet (2010) 3.31
D-dimer levels and risk of recurrent venous thromboembolism. JAMA (2003) 3.30
The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil (2005) 3.17
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood (2008) 2.97
Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell (2010) 2.91
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost (2007) 2.56
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36
The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med (2004) 2.27
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci (2004) 2.08
Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions. Radiology (2004) 2.07
Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med (2004) 1.98
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med (2010) 1.83
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol (2009) 1.78
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA (2006) 1.72
Dental and periodontal status and risk for progression of carotid atherosclerosis: the inflammation and carotid artery risk for atherosclerosis study dental substudy. Stroke (2006) 1.65
Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology (2002) 1.65
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J (2004) 1.64
High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica (2012) 1.62
Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med (Berl) (2007) 1.60
Human but not mouse adipogenesis is critically dependent on LMO3. Cell Metab (2013) 1.57
Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem (2007) 1.56
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol (2006) 1.52
Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med (2008) 1.52
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]. Wien Klin Wochenschr (2007) 1.51
Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. Radiology (2003) 1.51
Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis (2012) 1.49
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost (2006) 1.49
Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology (2003) 1.48
Carbon monoxide orchestrates a protective response through PPARgamma. Immunity (2006) 1.47
New diagnostic strategies for pulmonary embolism. Lancet (2008) 1.46
Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J Endovasc Ther (2003) 1.44
Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. J Vasc Interv Radiol (2005) 1.42
Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation (2005) 1.32
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care (2004) 1.32
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther (2008) 1.30
Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab (2007) 1.29
Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med (2012) 1.28
Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med (2009) 1.27
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology (2010) 1.23
Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes (2003) 1.20
Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology (2008) 1.20
Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J (2004) 1.19
The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost (2009) 1.18
Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res (2004) 1.18
Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res (2006) 1.17
High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation (2007) 1.16
The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr (2006) 1.16
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol (2004) 1.13
NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells. FASEB J (2009) 1.13
Is Virchow's triad complete? Blood (2009) 1.10
Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. Clin Chem (2008) 1.09
Deciphering regulatory patterns of inflammatory gene expression from interleukin-1-stimulated human endothelial cells. Arterioscler Thromb Vasc Biol (2004) 1.08
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism. Thromb Haemost (2005) 1.06
Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res (2002) 1.05
Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression? Stroke (2005) 1.03
Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One (2012) 1.00
C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke (2007) 1.00
Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost (2009) 1.00
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia. Int J Cancer (2007) 0.99
Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes (2002) 0.99
Cross-talk between interferon-γ and hedgehog signaling regulates adipogenesis. Diabetes (2011) 0.98
Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke (2011) 0.98
Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res (2002) 0.96
Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg (2005) 0.96
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J (2005) 0.96
Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion. Mol Cancer (2010) 0.96
Cross-regulation of carbon monoxide and the adenosine A2a receptor in macrophages. J Immunol (2007) 0.95
The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. Thromb Res (2004) 0.94
Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. PLoS One (2010) 0.94
Impact of alphaENaC polymorphisms on the risk of ischemic cerebrovascular events: a multicenter case-control study. Clin Chem (2005) 0.93
Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke (2010) 0.93
Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) (2013) 0.93
Family history for venous thromboembolism and the risk for recurrence. Am J Med (2006) 0.93
Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation (2003) 0.93
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J (2012) 0.93
Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease. J Lipid Res (2012) 0.93
Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells. FASEB J (2005) 0.93
Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease. Clin Chem (2012) 0.92
Candidate genetic risk factors of stroke: results of a multilocus genotyping assay. Clin Chem (2007) 0.91
The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem (2005) 0.91
Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med (2006) 0.91
Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur J Clin Invest (2012) 0.91
Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. J Am Coll Cardiol (2006) 0.90
Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism. Arch Intern Med (2006) 0.90
Low vitamin B6 levels and the risk of recurrent venous thromboembolism. Haematologica (2007) 0.89
Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab (2008) 0.89
High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting. Thromb Haemost (2004) 0.89
Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther (2002) 0.88
Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism. J Vasc Surg (2008) 0.88
Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke (2007) 0.88
Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology (2002) 0.88